AB
Aqur Biosciences, Inc.
SEC filingPharmaceuticals · Westlake Village, CA
Amount raised$1.5Msold at filing
Total offering$1.5M
Investors in the raise7count reported to the SEC
FiledSep 18, 2026first sale Sep 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michel F DenarieExecutive Officer
Jeffrey B WolinExecutive Officer, Director
Tomi K SawyerExecutive Officer
Michael A FoleExecutive Officer
James Hess LeachExecutive Officer
Executive officers, directors and promoters as listed on the Form D.